@Article{info:doi/10.2196/jmir.8617,
author="Koziol-McLain, Jane
and Vandal, Alain C
and Wilson, Denise
and Nada-Raja, Shyamala
and Dobbs, Terry
and McLean, Christine
and Sisk, Rose
and Eden, Karen B
and Glass, Nancy E",
title="Efficacy of a Web-Based Safety Decision Aid for Women Experiencing Intimate Partner Violence: Randomized Controlled Trial",
journal="J Med Internet Res",
year="2018",
month="Jan",
day="10",
volume="19",
number="12",
pages="e426",
keywords="eHealth; intimate partner violence; randomized controlled trial; New Zealand; depression; population groups",
abstract="Background: Intimate partner violence (IPV) is a human rights violation and leading health burden for women. Safety planning is a hallmark of specialist family violence intervention, yet only a small proportion of women access formal services. A Web-based safety decision aid may reach a wide audience of women experiencing IPV and offer the opportunity to prioritize and plan for safety for themselves and their families. Objective: The aim of this study was to test the efficacy of a Web-based safety decision aid (isafe) for women experiencing IPV. Methods: We conducted a fully automated Web-based two-arm parallel randomized controlled trial (RCT) in a general population of New Zealand women who had experienced IPV in the past 6 months. Computer-generated randomization was based on a minimization scheme with stratification by severity of violence and children. Women were randomly assigned to the password-protected intervention website (safety priority setting, danger assessment, and tailored action plan components) or control website (standard, nonindividualized information). Primary endpoints were self-reported mental health (Center for Epidemiologic Studies Depression Scale-Revised, CESD-R) and IPV exposure (Severity of Violence Against Women Scale, SVAWS) at 12-month follow-up. Analyses were by intention to treat. Results: Women were recruited from September 2012 to September 2014. Participants were aged between 16 and 60 years, 27{\%} (111/412) self-identified as M{\={a}}ori (indigenous New Zealand), and 51{\%} (210/412) reported at baseline that they were unsure of their future plans for their partner relationship. Among the 412 women recruited, retention at 12 months was 87{\%}. The adjusted estimated intervention effect for SVAWS was −12.44 (95{\%} CI −23.35 to −1.54) for M{\={a}}ori and 0.76 (95{\%} CI −5.57 to 7.09) for non-M{\={a}}ori. The adjusted intervention effect for CESD-R was −7.75 (95{\%} CI −15.57 to 0.07) for M{\={a}}ori and 1.36 (−3.16 to 5.88) for non-M{\={a}}ori. No study-related adverse events were reported. Conclusions: The interactive, individualized Web-based isafe decision aid was effective in reducing IPV exposure limited to indigenous M{\={a}}ori women. Discovery of a treatment effect in a population group that experiences significant health disparities is a welcome, important finding. Trial Registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12612000708853; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12612000708853 (Archived by Webcite at http://www.webcitation/61MGuVXdK) ",
issn="1438-8871",
doi="10.2196/jmir.8617",
url="http://www.jmir.org/2017/12/e426/",
url="https://doi.org/10.2196/jmir.8617",
url="http://www.ncbi.nlm.nih.gov/pubmed/29321125"
}